Immunopathology in PMM2-CDG: Defective glycosylation impact in the TNFα -TNFR1 signalling pathwayCarlota Pascoal(The Patients Association), Paula A. Videira(The Patients Association)Frontiers in ImmunologySeptember 18, 202510.3389/fimmu.2025.1655354Cited by 0SaveCiteExport RISWatch citationsRelated PapersInhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and <scp>ERK</scp>1/2 and p38 <scp>MAPK</scp> activation|Molecular Oncology|2017|64Unraveling the biological potential of skin fibroblast: responses to TNF-α, highlighting intracellular signaling pathways and secretome|Immunology Letters|2025|4